Clinical Trial Update: Dupilumab in Japanese Patients With Atopic Dermatitis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial of dupilumab in Japanese patients with atopic dermatitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• DUPIXENT (DUPILUMAB)

Snippet

Sponsor: Sanofi | Conditions: Atopic Dermatitis | Phase 3 | Status: COMPLETED